AU2016202471A1 - Molecules with extended half-lives, compositions and uses thereof - Google Patents
Molecules with extended half-lives, compositions and uses thereofInfo
- Publication number
- AU2016202471A1 AU2016202471A1 AU2016202471A AU2016202471A AU2016202471A1 AU 2016202471 A1 AU2016202471 A1 AU 2016202471A1 AU 2016202471 A AU2016202471 A AU 2016202471A AU 2016202471 A AU2016202471 A AU 2016202471A AU 2016202471 A1 AU2016202471 A1 AU 2016202471A1
- Authority
- AU
- Australia
- Prior art keywords
- lives
- molecules
- compositions
- extended half
- extended
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036499 Half live Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2016202471A AU2016202471C1 (en) | 2000-12-12 | 2016-04-19 | Molecules with extended half-lives, compositions and uses thereof |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/254,884 | 2000-12-12 | ||
US60/289,760 | 2001-05-09 | ||
AU2011253690A AU2011253690C1 (en) | 2000-12-12 | 2011-11-25 | Molecules with extended half-lives, compositions and uses thereof |
AU2014200579A AU2014200579C1 (en) | 2000-12-12 | 2014-02-03 | Molecules with extended half-lives, compositions and uses thereof |
AU2016202471A AU2016202471C1 (en) | 2000-12-12 | 2016-04-19 | Molecules with extended half-lives, compositions and uses thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2014200579A Division AU2014200579C1 (en) | 2000-12-12 | 2014-02-03 | Molecules with extended half-lives, compositions and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
AU2016202471A1 true AU2016202471A1 (en) | 2016-05-12 |
AU2016202471B2 AU2016202471B2 (en) | 2017-05-25 |
AU2016202471C1 AU2016202471C1 (en) | 2017-11-09 |
Family
ID=45442596
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2011253690A Expired AU2011253690C1 (en) | 2000-12-12 | 2011-11-25 | Molecules with extended half-lives, compositions and uses thereof |
AU2014200579A Expired AU2014200579C1 (en) | 2000-12-12 | 2014-02-03 | Molecules with extended half-lives, compositions and uses thereof |
AU2016202471A Expired AU2016202471C1 (en) | 2000-12-12 | 2016-04-19 | Molecules with extended half-lives, compositions and uses thereof |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2011253690A Expired AU2011253690C1 (en) | 2000-12-12 | 2011-11-25 | Molecules with extended half-lives, compositions and uses thereof |
AU2014200579A Expired AU2014200579C1 (en) | 2000-12-12 | 2014-02-03 | Molecules with extended half-lives, compositions and uses thereof |
Country Status (1)
Country | Link |
---|---|
AU (3) | AU2011253690C1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69731289D1 (en) * | 1996-03-18 | 2004-11-25 | Univ Texas | IMMUNGLOBULIN-LIKE DOMAIN WITH INCREASED HALF-VALUE TIMES |
WO1998023289A1 (en) * | 1996-11-27 | 1998-06-04 | The General Hospital Corporation | MODULATION OF IgG BINDING TO FcRn |
JP2002505086A (en) * | 1998-02-25 | 2002-02-19 | レキシジェン ファーマシューティカルズ コーポレイション | Enhanced circulating half-life of antibody-based fusion proteins |
-
2011
- 2011-11-25 AU AU2011253690A patent/AU2011253690C1/en not_active Expired
-
2014
- 2014-02-03 AU AU2014200579A patent/AU2014200579C1/en not_active Expired
-
2016
- 2016-04-19 AU AU2016202471A patent/AU2016202471C1/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001240473A1 (en) | Variants with altered properties | |
AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
MXPA02012749A (en) | B7-like molecules and uses thereof. | |
AU2001258229A1 (en) | Alpha-amylase variants with altered 1,6-activity | |
AU2001247788A1 (en) | 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor | |
AU2001215798A1 (en) | Click-to-add, jot-it-down, and add banner | |
AU2002219135A1 (en) | Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors | |
AU4196801A (en) | Chordin-like-2 molecules and uses thereof | |
AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
AU2002211717A1 (en) | Stresscopins and their uses | |
AU2001291132A1 (en) | Lymphoma associated molecules and uses therefor | |
AU2001283457A1 (en) | Styrenic polymer compositions with improved clarity | |
IL153573A0 (en) | Clk-2, cek-7 and coq-4 genes, and uses thereof | |
AU2001268186A1 (en) | Toughened polyacetal resin composition | |
AU2002224876A1 (en) | Isolated luciferases and the use thereof | |
AU3883800A (en) | Hob-bp2h compositions, methods and uses thereof | |
AU2001232089A1 (en) | Compound, composition and use | |
AU2016202471A1 (en) | Molecules with extended half-lives, compositions and uses thereof | |
AU2001232080A1 (en) | Compound, compositions and use | |
AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof | |
AU2001257404A1 (en) | 2246, novel protein kinase molecules and uses therefor | |
AU2001245974A1 (en) | 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor | |
AU2002311749A1 (en) | Narc10 and narc16, programmed cell death-associated molecules and uses thereof | |
AU2001238622A1 (en) | 7970, a novel atpase-like molecule and uses thereof |